CXCR4 blockade induces atherosclerosis by affecting neutrophil function.
暂无分享,去创建一个
V. Hérias | A. Zernecke | R. Koenen | C. Weber | T. V. van Berkel | J. Kuiper | Marco Manca | L. Su | I. Bot | L. Gullestad | S. D. de Jager | E. Biessen | B. Halvorsen | M. Skjelland | J. Sluimer | G. V. van Puijvelde | M. Bot | I. Daissormont | P. V. van Santbrink | M. Westra | P. Aukrust | B. Kramp
[1] Oliver Soehnlein,et al. Multiple roles for neutrophils in atherosclerosis. , 2012, Circulation research.
[2] C. Weber,et al. Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.
[3] Oliver Soehnlein,et al. Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis , 2010, Circulation.
[4] I. van der Made,et al. Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. , 2010, Cell metabolism.
[5] D. Link,et al. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. , 2010, The Journal of clinical investigation.
[6] F. Crea,et al. Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability. , 2009, European heart journal.
[7] F. Tacke,et al. Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis , 2008, Circulation research.
[8] M. Hristov,et al. Expression of HIF-1α in Injured Arteries Controls SDF-1α–Mediated Neointima Formation in Apolipoprotein E–Deficient Mice , 2007 .
[9] E. Falk,et al. Smooth Muscle Cells Healing Atherosclerotic Plaque Disruptions Are of Local, Not Blood, Origin in Apolipoprotein E Knockout Mice , 2007, Circulation.
[10] P. Shah. Molecular mechanisms of plaque instability , 2007, Current opinion in lipidology.
[11] A. Zernecke,et al. Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient Mice , 2007, Circulation.
[12] F. Mach,et al. The specific role of chemokines in atherosclerosis , 2007, Thrombosis and Haemostasis.
[13] R. Ransohoff,et al. The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.
[14] Aloke V. Finn,et al. Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[15] J. Seppen,et al. persistent knockdown of CCR2 function in vivo Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to , 2013 .
[16] B. Spellberg,et al. A phagocytic cell line markedly improves survival of infected neutropenic mice , 2005, Journal of leukocyte biology.
[17] G. Bren,et al. Elimination of Senescent Neutrophils by TNF-Related Apoptosis-Inducing Ligand1 , 2005, The Journal of Immunology.
[18] A. Zernecke,et al. SDF-1&agr;/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells , 2005, Circulation research.
[19] A. Zernecke,et al. Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[20] Renu Virmani,et al. Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.
[21] S. Saccani,et al. Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.
[22] L. Su,et al. A genetic approach to inactivating chemokine receptors using a modified viral protein , 2003, Nature Biotechnology.
[23] S. Rankin,et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. , 2003, Immunity.
[24] T. V. van Berkel,et al. Aorta of ApoE-Deficient Mice Responds to Atherogenic Stimuli by a Prelesional Increase and Subsequent Decrease in the Expression of Antioxidant Enzymes , 2003, Circulation research.
[25] D. Camerini,et al. Platelet Chemokines and Chemokine Receptors: Linking Hemostasis, Inflammation, and Host Defense , 2003, Microcirculation.
[26] S. Frøland,et al. Stromal Cell–Derived Factor-1&agr; in Unstable Angina: Potential Antiinflammatory and Matrix-Stabilizing Effects , 2002, Circulation.
[27] Peter Libby,et al. Current Concepts of the Pathogenesis of the Acute Coronary Syndromes , 2001, Circulation.
[28] R. Virmani,et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[29] P. Libby,et al. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. , 2000, Circulation research.
[30] B. Sykes,et al. Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.
[31] C. Bunce,et al. Growth of single HL60 cells in liquid culture: analysis of the influences of differentiative agents. , 1996, Leukemia research.